The present disclosure relates to spinal implants, methods, and devices. More specifically, the present disclosure relates to improved spinal implants, methods, and devices for spinal fusion in a patient.
Spinal fusion procedures utilizing spinal implants can be used to correct spinal conditions such as degenerative disc disease, disc herniations, spondylolisthesis, stenosis, scoliosis, spinal deformities, or other spinal conditions through minimally invasive or invasive spinal surgery. For example, two or more vertebrae may be experiencing instability, deformity, or another abnormality which causes pain and discomfort to the patient. After preparatory surgery, a fusion cage containing bone graft material may be inserted into a disc space, thereby allowing bone to grow and connect the vertebrae, eventually resulting in bone fusion. The preparatory surgeries include multiple different types, each with advantages or disadvantages based on the patient's condition, surgeons' capabilities, or improvements to the field throughout the years. Among the various surgeries are Posterior Lumber Interbody Fusion (PLIF), Transforaminal Lumber Interbody Fusion (TLIF), Anterior Lumbar Interbody Fusion (ALIF), and Oblique Lateral Interbody Fusion (OLIF).
Unfortunately, despite significant advances and improvements in the field, interbody procedures with cage insertion may still result nerve damage, instrument malfunction, or non-fusion. Accordingly, improved surgical systems, methods, and devices that reduce or eliminate these postoperative outcomes would be desirable.
The various systems and methods of the present disclosure have been developed in response to the present state of the art, and in particular, in response to the problems and needs in the art that have not yet been fully solved by currently available surgical instruments, devices, systems, and methods for implanting bone anchor assemblies in a patient.
According to some embodiments, an interbody implant may be used to fuse a superior vertebra and an inferior vertebra of a patient. The interbody implant may have a body with a solid, unitary structure. The body may define a superior side shaped to abut an inferior end plate of the superior vertebra, the superior side defining a first aperture, an inferior side shaped to abut a superior end plate of the inferior vertebra, the inferior side defining a second aperture, a leading end, a trailing end, a first lateral side, a second lateral side, and a bone growth cavity extending between the first aperture and the second aperture. The interbody implant may further include one or more porous layers that are secured to the superior side, the inferior side, the first lateral side, and the second lateral side by a homogenous interface between the body and the porous layer.
Each of the one or more porous layers may have a web-like scaffold having curved surfaces that define substantially spherical voids, the substantially spherical voids being interconnected at tangent points.
The web-like scaffold may have a material formed from a substantially uniform mixture of bone growth material and thermoplastic polymer.
The one or more porous layers may be a single porous layer that extends across the inferior side, the first lateral side, the superior side, and the second lateral side.
The one or more porous layers may terminate short of the leading end.
The leading end may include a solid bumper positioned to protect the one or more porous layers from abrasion against bone during insertion of the interbody implant between the superior vertebra and the inferior vertebra.
The leading end may include an exterior surface that is flush with adjoining exterior surfaces of the one or more porous layers.
At least one of the one or more porous layers may have a variable thickness.
At least one of the one or more porous layers may have a flat interior surface facing and secured to the superior side, the inferior side, the first lateral side, or the second lateral side, and a convex exterior surface.
The one or more porous layers may include a superior layer secured to the superior side, an inferior layer secured to the inferior side, a first lateral layer secured to the first lateral side, and a second lateral layer secured to the second lateral side. The body may include solid structures extending longitudinally between each of the superior layer, the inferior layer, the first lateral layer, and the second lateral layer.
The body may have a solid structure on the trailing end, the solid structure defining a non-porous interface that facilitates attachment of the interbody implant to an implant inserter. The one or more porous layers may extend to cover superior, inferior, and/or lateral aspects of the trailing end.
The one or more porous layers may further be secured to inwardly-facing surface of the bone growth cavity.
At least one of the superior side, the inferior side, the first lateral side, and the second lateral side may have a boss extending through the one or more porous layers.
According to some embodiments, an interbody implant may be used to fuse a superior vertebra and an inferior vertebra of a patient. The interbody implant may have a body with a solid, unitary structure. The body may define a superior side shaped to abut an inferior end plate of the superior vertebra, the superior side defining a first aperture, an inferior side shaped to abut a superior end plate of the inferior vertebra, the inferior side defining a second aperture, a leading end, a trailing end, a first lateral side, a second lateral side, and a bone growth cavity extending between the first aperture and the second aperture. The interbody implant may further include one or more porous layers that are secured to the superior side and the inferior side. At least one of the one or more porous layers may have a variable thickness.
At least one of the one or more porous layers may have a flat interior surface facing and secured to the superior side or the inferior side, and a convex exterior surface.
At least one of the one or more porous layers may have a leading edge at which the variable thickness approaches zero.
Each of the one or more porous layers may be formed of a substantially uniform mixture of bone growth material and thermoplastic polymer.
According to some embodiments, an interbody implant may be used to fuse a superior vertebra and an inferior vertebra of a patient. The interbody implant may have a body with a solid, unitary structure. The body may define a superior side shaped to abut an inferior end plate of the superior vertebra, the superior side defining a first aperture, an inferior side shaped to abut a superior end plate of the inferior vertebra, the inferior side defining a second aperture, a leading end, a trailing end, a first lateral side, a second lateral side, and a bone growth cavity extending between the first aperture and the second aperture. The interbody implant may further include one or more porous layers that are secured to the superior side and the inferior side. The leading end may include a solid bumper positioned to protect the one or more porous layers from abrasion against bone during insertion of the interbody implant between the superior vertebra and the inferior vertebra. The body may have a solid structure on the trailing end, the solid structure defining a non-porous interface that facilitates attachment of the interbody implant to an implant inserter. The one or more porous layers may extend to cover superior, inferior, and/or lateral aspects of the trailing end.
At least one of the one or more porous layers may have a variable thickness.
Each of the one or more porous layers may be formed of a substantially uniform mixture of bone growth material and thermoplastic polymer.
These and other features and advantages of the present disclosure will become more fully apparent from the following description and appended claims, or may be learned by the practice of the systems and methods set forth hereinafter.
Exemplary embodiments of the disclosure will become more fully apparent from the following description and appended claims, taken in conjunction with the accompanying drawings. Understanding that these drawings depict only exemplary embodiments and are, therefore, not to be considered limiting of the scope of the appended claims, the exemplary embodiments of the present disclosure will be described with additional specificity and detail through use of the accompanying drawings in which:
It is to be understood that the drawings are for purposes of illustrating the concepts of the disclosure and may not be drawn to scale. Furthermore, the drawings illustrate exemplary embodiments and do not represent limitations to the scope of the present disclosure.
Exemplary embodiments of the present disclosure will be best understood by reference to the drawings, wherein like parts are designated by like numerals throughout. It will be readily understood that the components of the present disclosure, as generally described and illustrated in the Figures herein, could be arranged and designed in a wide variety of different configurations. Thus, the following more detailed description of the embodiments of the apparatus and method, as represented in the Figures, is not intended to limit the scope of the present disclosure, as claimed in this or any other application claiming priority to this application, but is merely representative of exemplary embodiments of the present disclosure.
Standard medical directions, planes of reference, and descriptive terminology are employed in this specification. For example, anterior means toward the front of the body. Posterior means toward the back of the body. Superior means toward the head. Inferior means toward the feet. Medial means toward the midline of the body. Lateral means away from the midline of the body. Axial means toward a central axis of the body. Abaxial means away from a central axis of the body. Ipsilateral means on the same side of the body. Contralateral means on the opposite side of the body. A sagittal plane divides a body into right and left portions. A midsagittal plane divides the body into bilaterally symmetric right and left halves. A coronal plane divides a body into anterior and posterior portions. A transverse plane divides a body into superior and inferior portions. These descriptive terms may be applied to an animate or inanimate body.
The phrases “connected to,” “coupled to” and “in communication with” refer to any form of interaction between two or more entities, including mechanical, electrical, magnetic, electromagnetic, fluid, and thermal interaction. Two components may be functionally coupled to each other even though they are not in direct contact with each other. The term “abutting” refers to items that are in direct physical contact with each other, although the items may not necessarily be attached together. The phrase “fluid communication” refers to two features that are connected such that a fluid within one feature is able to pass into the other feature.
The word “exemplary” is used herein to mean “serving as an example, instance, or illustration.” Any embodiment described herein as “exemplary” is not necessarily to be construed as preferred or advantageous over other embodiments. While the various aspects of the embodiments are presented in drawings, the drawings are not necessarily drawn to scale unless specifically indicated.
Described herein are implants for spinal surgery and/or correction, including but not limited to Posterior Lumber Interbody Fusion (PLIF), Transforaminal Lumber Interbody Fusion (TLIF), Anterior Lumbar Interbody Fusion (ALIF), and Oblique Lateral Interbody Fusion (OLIF). The geometry of the implant, surface area of porous surfaces, thickness of porous surfaces, lordotic angle of the implant, structure, shape, size, and other characteristics of the implant may be tailored to the intended use.
Optionally, the implant 100 may be combined with other implants (not shown), such as bone plates, pedicle screw and rod systems, another fusion cage (e.g., identical or dissimilar), and/or the like in order to further immobilize the joint defined between the superior and inferior vertebrae while fusion occurs. In the alternative, the implant 100 may be a “standalone” implant designed to function independently of other implants.
The trailing end 114 of the implant 100 may have one or more inserter connection features. In the exemplary embodiment of
The implant 100 may further have one or more features that facilitate visualization of the implant 100 under X-ray, fluoroscopy, and/or other imaging techniques. For example, the implant 100 may have a first radiographic marker 152, a second radiographic marker 154, and a third radiographic marker 156. The first radiographic marker 152, the second radiographic marker 154, and the third radiographic marker 156 may be made of a biocompatible, radio-opaque material that will be visible under fluoroscopy. For example, the first radiographic marker 152, the second radiographic marker 154, and the third radiographic marker 156 may be made of Titanium or the like. The first radiographic marker 152, the second radiographic marker 154, and the third radiographic marker 156 may be formed in any shape, including but not limited to spheres, rods, and pins, and may be vertically-oriented pins in the embodiment of
As shown, the first radiographic marker 152, the second radiographic marker 154, and the third radiographic marker 156 may all extend superior-inferiorly. The first radiographic marker 152 and the second radiographic marker 154 may be proximate the leading end 112, and the third radiographic marker 156 may be proximate the trailing end 114. As shown, the first radiographic marker 152 and the third radiographic marker 156 may be inserted through holes 158 in the superior side 102, and the second radiographic marker 154 may be inserted through a hole 158 in the inferior side 104. A diameter of the holes (e.g., hole 158) in a porous layer 160 (discussed below) of the implant 100 may be larger than a diameter of the holes in the remaining portion of the body of the implant 100 to facilitate ease of insertion of the radiographic markers.
At least some surfaces of the implant 100 may be designed to facilitate bone in-growth, through-growth, and/or bone on-growth with the implant 100. For example, one or more surfaces of the implant 100 may be porous to promote growth of bone into the surfaces, thereby enhancing adherence of the implant 100 to the superior and/or inferior vertebrae and/or bone growth between the superior and inferior vertebrae. The pores may be large and/or small (for example, nanoscale).
According to some examples, at least part of the implant 100 may be formed of a structurally modified (e.g., porous), biocompatible material such as a porous PEEK, Titanium, Cobalt Chromium, or the like. The pores may have a wide range of sizes, for example, from 1 μm to 10,000 μm, or more precisely from 10 μm to 5,000 μm, or even more precisely from 100 μm to 1,000 μm.
In alternative embodiments, the pores may have a narrow range of sizes. For example, the pores may range in size from 200 μm to 600 μm, or more precisely, from 300 μm to 500 μm, or even from 350 μm to 400 μm. If desired, the pores may be formed in a pattern such that the pores are connected at tangent points within the material. Thus, not only pores adjacent to the surface of the material, but also pores underneath the surface may be available for bone in-growth. In some embodiments, methods such as those set forth in U.S. Pat. No. 10,485,897, which is incorporated herein by reference, may be used to generate such pores. The pores may exist in a relatively even pattern (i.e., a “matrix”), rather than a random arrangement.
The pores may have any shape. In some embodiments, they may be spherical. In alternative embodiments, their shapes may be oblong, trapezoidal, rectangular prisms, pyramidal, conical, or the like. Any combination of rectilinear and/or organic shapes may be used.
In embodiments having spherical pores, the structural portion of the porous material comprises a scaffold of curved surfaces, having spherical voids that are substantially interconnected at tangent points of the spherical voids and/or curved surfaces. Generally, (meaning not limited to only spherical pore embodiments), the pores may have a wide range of interconnectivity, for example, from 40% to 90% interconnectivity, or more precisely from 50% to 80% interconnectivity, or even more precisely from 60% to 70% interconnectivity.
In some embodiments, the entirety of the implant 100 may have the same porous structure (for example, porous PEEK). In alternative embodiments, the implant 100 may exist as a combination of solid and porous portions (for example, solid PEEK and porous PEEK), with the porous portion defining a superficial layer on one or more surfaces of the implant 100. Such a superficial layer may have a thickness within the range of 0.01 mm to 5 mm, or more precisely, from 0.1 mm to 2 mm, or yet more precisely, from 0.2 mm to 1 mm, or still more precisely, from 0.3 mm to 0.6 mm.
Such a porous layer may exist only on bone-facing surfaces of the implant 100 (for example, on the superior side 102 and the inferior side 104, or more specifically on the portions of the superior side 102 and the inferior side 104 that will be in direct contact with the bone of the superior and inferior vertebrae. In the alternative, such a porous layer may wrap around to additional surfaces of the implant 100. This is the configuration shown in
In the exemplary embodiment of
Further, in the exemplary embodiment of
In addition to or in the alternative to the porous layer 160, one or more surfaces of the implant 100 may be coated and/or infused with an osteogenic substance designed to promote bone growth. For example, various calcium phosphates may be used, including hydroxyapatite (“HA”). Such materials may be provided as a surface layer or coating, or may be seated deeper in a porous structure. The osteogenic coating or infusion may facilitate and/or enhance the osseointegration process during the early stages of healing.
In some embodiments, where the osteogenic material is applied as a coating, the coating may be applied to the entire exterior of the implant 100. In the alternative, such a coating may be applied only to the porous layer 160 of the implant 100. The thickness of the coating may be within the range of 0.001 μm to 1 μm in thickness, or more precisely, 0.01 μm to 0.1 μm, or yet more precisely, from 0.015 μm to 0.05 μm. In some embodiments, the thickness of the coating may be about 0.02 μm (20 nm). Use of such a thin coating may help to preserve the porosity of the porous layer 160 (or in alternative embodiments, the porosity of the entire implant), while still providing the osteogenic properties mentioned above. The thin coating may additionally or alternatively eliminate at least some of the risks associated with thicker osteogenic coatings, such as poor coating integration and poor mechanical stability.
In addition to or in the alternative to a coating, the osteogenic material may be incorporated into the material of the cage. For example, the implant 100 may be made of HA PEEK, or a combination of HA PEEK and porous PEEK and/or porous HA PEEK.
Additionally or alternatively, the osteogenic material may be infused into the material of which the implant 100 is formed, or the porous portion thereof. Osteogenic material may consist of, but is not limited to: Hydroxyapatite (HA), Sintered and/or Unsintered calcium phosphate compound, Amorphous CaP (ACP), Biphasic CaP (BCP), Tetracalcium Phosphate (TTCP), Dicalcium Phosphate Anhydrous (DCPA), Dicalcium Phosphate Dihydrate (DCPD), Tricalcium Phosphate (TCP), Alpha-Tricalcium Phosphate (alpha-TCP), Beta-Tricalcium phosphate (beta-TCP), and/or combinations of the foregoing. The osteogenic material could also consist of a substituted HA, TCP, & BCP; wherein each substituted CaP can be synthesized with some of the atoms of Ca or some of the PO4 molecules replaced by other elements or molecules to bring about certain desirable biologic responses. Calcium phosphate compounds can have substitution of F, Ag, Sr, Mg, Zn and CO3. For example, the implant 100 may be formed of porous PEEK infused with HA. The HA may be distributed uniformly or substantially uniformly throughout the porous PEEK material, making it a porous PEEK HA structure. As another example, the implant 100 may be formed of a combination of solid and porous PEEK materials, with the PEEK existing as a layer such as porous layer 160, in which HA is infused only throughout the porous layer 160. In yet another example, the implant 100 may be formed of two separate portions. The first portion is a combination of HA and PEEK (e.g., HA distributed uniformly throughout the PEEK), neither of which is porous. The second portion is also a combination of HA and PEEK, formed together with porogen (e.g., spherical salt particles), which are subsequently leached out, making the second portion porous. The two portions may then be fused together by applying heat sufficient to melt at least one of the two portions to the other of the two portions. In some embodiments, both portions include an organic polymer or an organic thermoplastic polymer, such as s polyaryletherketone (PAEK), PEEK, polyethylene glycol (PEG), polvinylpyrrolidone (PVP), polyvinyl alcohol (PVA), or combinations thereof.
In some embodiments, the osteogenic material is inserted into the cavity 130 before the implant 100 is inserted into the patient. Additionally or alternatively, osteogenic material may be placed around the implant 100 after implantation. The osteogenic material may be inserted as a fluid, a viscous fluid, a non-Newtonian fluid, a putty, or combinations thereof. The osteogenic material may include HA, tricalcium phosphate (TCP), biphasic calcium phosphate, polymethylmethacrylate (PMMA), monocalcium phosphate, calcium carbonate, calcium sulphate, or combinations thereof.
In some embodiments, the homogeneous interface 166 includes a material of the porous layer 160 fused to the non-porous interface 168 of the body core as a result of a thermal process. For example, referring now to
Many different combinations of porosity and osteogenic material may be used within the scope of the present disclosure. Four exemplary combinations will be presented below:
The shape of the implant 100 is merely exemplary. Implants according to the present disclosure may be made in a wide variety of shapes and sizes.
The implant 700 may have a superior exterior surface 782 and/or inferior exterior surface (not shown) that abuts an adjoining exterior surface of the porous layer 760. The superior exterior surface 782 is a portion of a bumper structure (e.g., similar or identical, except in size, to superior solid bumper 162). The implant 700 may further include rounded, beveled, or chamfered corners and/or edges 784. The angle or radius of curvature of the bevel/chamfer of the corners and/or edges 784 may be increased or decreased during manufacture of the implant 700, depending on the intended use, desired amount of friction, angle of insertion of the implant, manufacture technique and/or technology used to manufacture the implant 700, or combinations thereof.
The implant 1100 may be an anterior lumbar interbody fusion (“ALIF”) implant designed to be inserted between the superior and inferior vertebrae from an anterior approach. The implant 1100 may have a cavity 1130 that similarly promotes fusion between the superior and inferior vertebrae. The implant 1100 may further have a porous layer 1160 facing the superior and inferior vertebrae, and optionally, covering the inwardly-facing surfaces of the cavity 1130. Additionally, the implant 1100 may have one or more inserter connection features 1150 on the anterior side of the implant 1100. The inserter connection features 1150 may be arranged on one side of the anterior aspect of the implant 1100 to facilitate insertion of the implant 1100 along an antero-lateral approach. The implant 1100 may be designed for use with a bone plate, pedicle screw and rod system, and/or other fixation applied between the superior and inferior vertebrae.
The implant 1200 may be a transverse lateral interbody fusion (“TLIF”) implant designed to be inserted between the superior and inferior vertebrae from a transverse lateral approach. The implant 1200 may have a cavity 1230 that similarly promotes fusion between the superior and inferior vertebrae. The implant 1200 may further have a porous layer 1260 facing the superior and inferior vertebrae, and optionally, covering the inwardly-facing surfaces of the cavity 1230. Additionally, the implant 1200 may have one or more inserter connection features 1250 on the posterior side of the implant 1200. The inserter connection features 1250 may facilitate insertion of the implant 1200 along a transverse lateral and/or posterior approach.
The implant 1300 may be a stand-alone anterior lumbar interbody fusion (“ALIF”) implant designed to be inserted between the superior and inferior vertebrae from an anterior approach. The implant 1300 may have a cavity 1330 that similarly promotes fusion between the superior and inferior vertebrae. The implant 1300 may further have a porous layer 1360 facing the superior and inferior vertebrae, and optionally, covering the inwardly-facing surfaces of the cavity 1330. Additionally, the implant 1300 may have one or more inserter connection features 1350 on the anterior side of the implant 1300. The inserter connection features 1350 may be arranged on the anterior aspect of the implant 1300 to facilitate insertion of the implant 1300 along an anterior approach.
The implant 1300 may be designed for use without any additional fixation between the superior and inferior vertebrae. Thus, in addition to the inserter connection features 1350, the implant 1300 may have screw holes 1370 that are angled superiorly and inferiorly to receive bone screws that anchor the implant 1300 directly in the inferior and superior vertebrae. The implant 1300 may further have a hole 1380 that receives an anti-backout device, such as a rotor, that can be deployed to keep the bone screws from backing out of the superior and inferior vertebrae.
The implant 1400 may be a stand-alone implant, similar to implant 1300, except that implant 1400 includes two body cores that fit together (see
The implant 1400 further includes a lordotic angle adjustment feature, which is depicted as a pin 1468. Although depicted as a single pin that fits within the corresponding depressions in the two body cores, the pin 1468 may be exchanged with one of multiple different pins each having larger or smaller diameters. For example, if a surgeon wishes to increase or decrease the lordotic angle, they need only use a larger or smaller diameter pin 1468. Although the pin 1468 is depicted as a circular column, other pin shapes are contemplated and included herein. It is also important to note that the lordotic angle adjustment feature may further include a variable thickness porous layer 160 (e.g., thicker layer at the trailing end as compared to the leading end), the connection feature (e.g., convex portion 1470) discussed below, or combinations thereof.
In
The bumper 1562 extends around the perimeter of the body near the leading edge of the implant 1500. The bumper 1562 protects the porous layer 1560 that extends across the lateral sides, superior, and inferior surfaces of the implant 1500, as depicted in
The leading edge of the implant 1600 includes an immediate transition edge 1686, where the porous material transitions immediately to the material of the solid, non-porous bumper. The inferior and/or superior surface of the body of the implant 1600 includes a flat interior surface 1690. The flat interior surface 1690 does not include a bow or curve in any portion of the surface that extends away from the lip of the bumper up to the trailing edge of the elongated bone growth cavity of the implant 1600. Directly behind and adjacent to the trailing edge of the elongated bone growth cavity is a boss 1691 (e.g., protrusion) of the implant that may interface with the insertion tool or may protect the porous later 1660 at the trailing end of the implant 1600.
The leading end of the implant 1700 may not have linear corners or edges, but rather includes rounded edges and/or corners 1784. The radius of curvature of the rounded edges and/or corners 1784 may be tailorable during manufacturing and may improve the manufacturing process associated with manufacturing the implant 1700. For example, removing a device with rounded corners/edges from a mold may be easier than removing linear devices with linear corners/edges. The shape of the edges and/or corners 1784 may also improve the process of inserting the implant 1700 into the body of the patient (i.e., as compared to inserting implants with linear corners/edges).
The implant 1700 may further include a flat interior surface 1790 and a shoulder 1792 located near the trailing end and on a lateral side 1722 of the implant 1700. The shoulder 1792 may be used as a transition surface near the bumper instead of the lip that was previously discussed. The shoulder 1792 will provide a transitioning edge to the porous layer 1760, instead of an immediate transition from porous material to solid material, as was previously discussed.
As depicted in
As depicted in
The porous layer 1860 of the implant 1800 further includes transition edges, located at least on the inferior and/or superior surface. The transition edges occur where the material of the surface of the implant 1800 gradually transitions from the material of the porous layer 1860 to the material of the solid, non-porous body core of the implant 1800. Although the transition edges are depicted as abutting the solid bumper 1862 on the superior and inferior surfaces of the implant, in other embodiments the transition edges may be positioned to abut the solid bumper at one or both of the lateral sides 1822.
In some embodiments, at least one of the superior side, the inferior side, the first lateral side, and the second lateral side of the implant 1800 includes a boss 1891 extending through one or more of the porous layers 1860. For example, the boss 1891 may extend fully or partially through the superior portion of the porous layer 1860.
In some embodiments, the implant 1900 includes lateral aspects 1993 for accommodating an implant inserter. In other embodiments, the aspects of the implant 1900 for accommodating the implant inserter are not limited to the lateral aspects 1993 but may further include superior and/or inferior aspects. In yet other embodiments, the lateral aspects 1993 may be replaced by the superior and/or inferior aspects that accommodate the implant inserter.
As depicted in
In
As depicted in
In some embodiments, the implant 2000 may include a solid structure 2097 on the trailing end of the interbody implant. The solid structure 2097 may define a non-porous interface that facilitates attachment of the interbody implant 2000 to an implant inserter.
As depicted in
The material thickness of the porous structures 2098 may be variable, uniform, or both. For example, the flat lateral sides, depicted in
In
Any methods disclosed herein comprise one or more steps or actions for performing the described method. The method steps and/or actions may be interchanged with one another. In other words, unless a specific order of steps or actions is required for proper operation of the embodiment, the order and/or use of specific steps and/or actions may be modified.
Reference throughout this specification to “an embodiment” or “the embodiment” means that a particular feature, structure or characteristic described in connection with that embodiment is included in at least one embodiment. Thus, the quoted phrases, or variations thereof, as recited throughout this specification are not necessarily all referring to the same embodiment.
Similarly, it should be appreciated that in the above description of embodiments, various features are sometimes grouped together in a single embodiment, Figure, or description thereof for the purpose of streamlining the disclosure. This method of disclosure, however, is not to be interpreted as reflecting an intention that any claim requires more features than those expressly recited in that claim. Rather, as the following claims reflect, inventive aspects lie in a combination of fewer than all features of any single foregoing disclosed embodiment. Thus, the claims following this Detailed Description are hereby expressly incorporated into this Detailed Description, with each claim standing on its own as a separate embodiment. This disclosure includes all permutations of the independent claims with their dependent claims.
Recitation in the claims of the term “first” with respect to a feature or element does not necessarily imply the existence of a second or additional such feature or element. Elements recited in means-plus-function format are intended to be construed in accordance with 35 U.S.C. § 112 Para. 6. It will be apparent to those having skill in the art that changes may be made to the details of the above-described embodiments without departing from the underlying principles set forth herein.
While specific embodiments and applications of the present disclosure have been illustrated and described, it is to be understood that the scope of the appended claims is not limited to the precise configuration and components disclosed herein. Various modifications, changes, and variations which will be apparent to those skilled in the art may be made in the arrangement, operation, and details of the methods and systems disclosed herein.
This application claims the benefit of U.S. Provisional Patent Application Ser. No. 63/326,246 entitled “POROUS INTERBODY IMPLANT,” filed on Mar. 31, 2022, the disclosure of which is incorporated herein by reference in its entirety.
Number | Date | Country | |
---|---|---|---|
63326246 | Mar 2022 | US |